KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Receivables (2018 - 2025)

Historic Receivables for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $62.4 million.

  • Twist Bioscience's Receivables rose 5153.82% to $62.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $62.4 million, marking a year-over-year increase of 5153.82%. This contributed to the annual value of $60.9 million for FY2025, which is 6482.37% up from last year.
  • Twist Bioscience's Receivables amounted to $62.4 million in Q4 2025, which was up 5153.82% from $60.9 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Receivables ranged from a high of $62.4 million in Q4 2025 and a low of $2.0 million during Q3 2021
  • In the last 5 years, Twist Bioscience's Receivables had a median value of $42.5 million in 2022 and averaged $42.3 million.
  • In the last 5 years, Twist Bioscience's Receivables plummeted by 9268.12% in 2021 and then skyrocketed by 208470.0% in 2022.
  • Over the past 5 years, Twist Bioscience's Receivables (Quarter) stood at $38.7 million in 2021, then increased by 28.38% to $49.7 million in 2022, then decreased by 23.82% to $37.9 million in 2023, then grew by 8.71% to $41.2 million in 2024, then skyrocketed by 51.54% to $62.4 million in 2025.
  • Its Receivables stands at $62.4 million for Q4 2025, versus $60.9 million for Q3 2025 and $50.9 million for Q2 2025.